We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+9.93%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$94.1B
AUM Growth
+$4.41B
Cap. Flow
-$2.7B
Cap. Flow %
-2.86%
Top 10 Hldgs %
17.76%
Holding
4,266
New
89
Increased
1,934
Reduced
1,505
Closed
363

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$231M
2
QCOM icon
Qualcomm
QCOM
+$103M
3
MS icon
Morgan Stanley
MS
+$65.2M
4
WOLF icon
Wolfspeed
WOLF
+$56.8M
5
EWZ icon
iShares MSCI Brazil ETF
EWZ
+$56.7M

Sector Composition

Rank Sector Weight
1 Technology 21.39%
2 Healthcare 16.95%
3 Financials 14.35%
4 Consumer Discretionary 8.91%
5 Industrials 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THRX
3701
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$5 ﹤0.01%
1
-93
-99% -$545
MPLN.WS
3702
DELISTED
MultiPlan Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
MPLN.WS
$5 ﹤0.01%
100
CELL
3703
DELISTED
PhenomeX Inc. Common Stock
CELL
$5 ﹤0.01%
2
-316
-99% -$833
ATCX
3704
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$5 ﹤0.01%
1
-102
-99% -$636
YELL
3705
DELISTED
Yellow Corporation Common Stock
YELL
$5 ﹤0.01%
2
AIP icon
3706
Arteris
AIP
$1.46B
$4 ﹤0.01%
1
-96
-99% -$484
AMTX icon
3707
Aemetis
AMTX
$115M
$4 ﹤0.01%
1
-165
-99% -$937
CLSK icon
3708
CleanSpark
CLSK
$3.27B
$4 ﹤0.01%
2
-255
-99% -$660
DSP icon
3709
Viant Technology
DSP
$247M
$4 ﹤0.01%
1
-79
-99% -$319
EYPT icon
3710
EyePoint Inc
EYPT
$1.08B
$4 ﹤0.01%
1
-146
-99% -$644
HFFG icon
3711
HF Foods Group
HFFG
$78.1M
$4 ﹤0.01%
1
-200
-100% -$843
LOCL icon
3712
Local Bounti
LOCL
$22.3M
-3,722
Closed -$116K
BINI
3713
DELISTED
Bollinger Innovations
BINI
0
NAUT icon
3714
Nautilus Biotechnolgy
NAUT
$113M
$4 ﹤0.01%
2
-264
-99% -$510
TEAD
3715
Teads Holding Co
TEAD
$67.5M
$4 ﹤0.01%
1
-218
-100% -$854
QUAD icon
3716
Quad
QUAD
$515M
$4 ﹤0.01%
1
-189
-99% -$601
RBOT
3717
DELISTED
Vicarious Surgical
RBOT
-10
Closed -$930
TTSH
3718
DELISTED
Tile Shop Holdings
TTSH
$4 ﹤0.01%
1
-204
-100% -$839
TBIO
3719
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
0
OMIC
3720
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
-11
Closed -$737
VIEW
3721
DELISTED
View, Inc. Class A Common Stock
VIEW
-11
Closed -$804
CURO
3722
DELISTED
CURO Group Holdings Corp.
CURO
$4 ﹤0.01%
1
-12,126
-100% -$46.2K
THRN
3723
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$4 ﹤0.01%
1
-75
-99% -$333
FRBK
3724
DELISTED
Republic First Bancorp Inc
FRBK
$4 ﹤0.01%
2
-271
-99% -$719
BBIG
3725
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
-5,575
Closed -$85.7K

Similar funds

Credit Suisse's Q4 2022 Portfolio in Review

As of Q4 2022, Credit Suisse held 4,266 positions worth $94.1B, up 4.9% from $89.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Credit Suisse's Q4 2022 filing shows 89 new, 1,934 increased, 1,505 reduced and 363 closed positions. Its largest new stake was iShares World ex U.S. Carbon Transition Readiness Aware Active ETF: 1,400,000 shares worth $54M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $323M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • Credit Suisse's largest Q4 2022 buy was iShares World ex U.S. Carbon Transition Readiness Aware Active ETF: 1,400,000 shares worth $54M.
  • Credit Suisse added most to Amazon in Q4 2022, an estimated $231M increase.
  • Credit Suisse's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $323M.
  • Credit Suisse fully exited Citrix Systems Inc in Q4 2022, selling an estimated $150M.
  • Credit Suisse's ten largest holdings make up 18% of its $94.1B portfolio in Q4 2022.
  • Credit Suisse opened 89 new positions and closed 363 in Q4 2022.
  • Credit Suisse's portfolio value rose 4.9% quarter-over-quarter to $94.1B.

Based on Credit Suisse's 13F filing for Q4 2022, filed 13 Feb 2023.